Cite
HARVARD Citation
Zeidan, A. et al. (n.d.). Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?. American journal of hematology. 90 (11), pp. 1036-1040. [Online].